Stock listing

NASDAQ:ACHN Achillion Pharmaceuticals Inc Stock

Follow Achillion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ACHN

$6.76 USD

Close on Jan 27, 2020 · No longer trades

Oct 26, 2006 to last close -45.4% · monthly closes, Oct 26, 2006 – Jan 27, 2020
Lowest – highest close
$0.68 – $19.61 USDSince Oct 26, 2006 · lowest Dec 31, 2008 · highest Feb 1, 2007

Delisted NASDAQ:ACHN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ACHN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Achillion Pharmaceuticals Inc on 6ix

Decks
2 decks · latest Nov 20, 2019

Where Achillion Pharmaceuticals Inc is listed

ListingExchangeCountryCurrency
NASDAQ:ACHN · This page · DelistedNASDAQUnited StatesUSD
OTC:ACHN · DelistedOTCUnited StatesUSD

Decks

DeckKindSlidesDate
Merger or Acquisition (November 2019)Merger or acquisition23 slidesNov 20, 2019
Technical Presentation (May 2019)Technical33 slidesMay 17, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Grey
Other companies: OnKure Therapeutics, Inc. (Chairman · Since at least Apr 8, 2021); Spruce Biosciences, Inc. (Executive Chairman · Since at least Oct 8, 2020); Mirum Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2019); Horizon Pharma PLC (Director · Sep 29, 2011 – May 3, 2018 · Past); BioMarin Pharmaceutical Inc. (Director · Dec 14, 2006 – Mar 5, 2021 · Past); Idm Pharma Inc (Director · Jun 14, 2006 – Dec 11, 2008 · Past); SGX Pharmaceuticals Inc (President & CEO, Director · Jan 31, 2006 – Aug 20, 2008 · Past)
Director · Oct 25, 2006 – Dec 18, 2009 · Past
Mary Kay Fenton
Other companies: Cullinan Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 29, 2024); Tourmaline Bio Inc. (Chief Financial Officer · May 6, 2021 – Jul 3, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past)
Chief Financial Officer · Dec 12, 2011 – Feb 9, 2018 · Past
Kurt Graves
Other companies: Seres Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Radius Health, Inc. (Director · Feb 13, 2018 – Feb 20, 2020 · Past)
Director · Feb 9, 2018 – Jan 28, 2020 · Past
Michael D Kishbauch
Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2016); Progenics Pharmaceuticals Inc (Director · Jun 8, 2016 – Jul 11, 2019 · Past)
Director · Jan 25, 2016 – Jan 28, 2020 · Past
Nicholas Simon
Other companies: Gritstone bio, Inc. (Director · Sep 27, 2018 – Jun 18, 2020 · Past); Sientra Inc (Director · Oct 28, 2014 – Jun 10, 2021 · Past)
Director · Aug 20, 2010 – Jun 4, 2012 · Past
Elizabeth A Olek
Other companies: Kronos Bio Inc (SR VP, CLINICAL SCIENCE · Feb 16, 2024 – Feb 21, 2024 · Past)
SVP and CMO · Dec 15, 2008 – Jan 10, 2012 · Past
Frank Verwiel
Other companies: Intellia Therapeutics, Inc. (Director · Since at least May 21, 2019)
Director · Jan 28, 2020 – Jan 28, 2020 · Past
Paul E Firuta
Other companies: uniQure N.V. (Chief Commercial Officer · Dec 13, 2017 – Jan 26, 2018 · Past)
EVP, Chief Commercial Officer · Sep 10, 2018 – Jan 28, 2020 · Past
David ScheerDirector · Nov 13, 2019 – Jan 28, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Achillion Pharmaceuticals Inc.